Researchers Say ctDNA Can Predict Which Patients With NSCLC Will Relapse After Surgical Resection

Cancer Therapy Advisor (4/29, Primeau) reports researchers found in the TRACERx study that “minimal residual disease detection by circulating tumor DNA (ctDNA) predicted patients with stage I to III non-small cell lung cancer (NSCLC) who would relapse aft...